These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8665535)

  • 1. Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease.
    García Ruiz PJ; Mena MA; Sanchez Bernardos V; Díaz Neira W; Gimenez Roldan S; Benitez J; García de Yebenes J
    Clin Neuropharmacol; 1995 Feb; 18(1):58-63. PubMed ID: 8665535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
    Kurlan R; Goldblatt D; Zaczek R; Jeffries K; Irvine C; Coyle J; Shoulson I
    Ann Neurol; 1988 Aug; 24(2):282-4. PubMed ID: 2972251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemistry of dopamine in Huntington's dementia and normal aging.
    Stahl SM; Thiemann S; Faull KF; Barchas JD; Berger PA
    Arch Gen Psychiatry; 1986 Feb; 43(2):161-4. PubMed ID: 2936315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington's disease: evidence for an overactive dopaminergic brain transmission.
    Garrett MC; Soares-da-Silva P
    J Neurochem; 1992 Jan; 58(1):101-6. PubMed ID: 1309230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
    Stanley M; Traskman-Bendz L; Dorovini-Zis K
    Life Sci; 1985 Oct; 37(14):1279-86. PubMed ID: 2413327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amine metabolites in the cerbrospinal fluid in Huntington's chorea.
    Curzon G; Gumpert J; Sharpe D
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):514-9. PubMed ID: 4261957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea.
    Mattsson B; Persson SA
    Acta Psychiatr Scand Suppl; 1974; 255():245-59. PubMed ID: 4282556
    [No Abstract]   [Full Text] [Related]  

  • 10. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 12. CSF monamine metabolites in movement disorders and normal aging.
    Stahl SM; Faull KF; Barchas JD; Berger PA
    Arch Neurol; 1985 Feb; 42(2):166-9. PubMed ID: 2579626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
    Sourkes TL; Young SN; Garelis E; Lal S
    Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical aspects of Huntington's chorea.
    Caraceni T; Calderini G; Consolazione A; Riva E; Algeri S; Girotti F; Spreafico R; Branciforti A; Dall'olio A; Morselli PL
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):581-7. PubMed ID: 143508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 16. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism.
    Naumann M; Götz M; Reiners K; Lange KW; Riederer P
    J Neural Transm (Vienna); 1996; 103(8-9):1083-91. PubMed ID: 9013396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results.
    Maira G; Bareggi SR; Di Rocco C; Calderini G; Morselli PL
    J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):123-8. PubMed ID: 1151392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
    Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
    Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.